These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10222438)

  • 21. S100beta as a predictor of brain metastases: brain versus cerebrovascular damage.
    Vogelbaum MA; Masaryk T; Mazzone P; Mekhail T; Fazio V; McCartney S; Marchi N; Kanner A; Janigro D
    Cancer; 2005 Aug; 104(4):817-24. PubMed ID: 15971200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrospinal fluid carcinoembryonic antigen and alphafetoprotein in patients with central nervous system neoplasia.
    Rombos A; Evangelopoulu-Katsiri E; Mariatos P; Katsouyanni K; Papagegorgiou C
    Acta Neurol Scand; 1988 Jun; 77(6):440-4. PubMed ID: 2457289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
    J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating endothelial progenitor cells in malignant gliomas.
    Rafat N; Beck GCh; Schulte J; Tuettenberg J; Vajkoczy P
    J Neurosurg; 2010 Jan; 112(1):43-9. PubMed ID: 19522573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-P53 antibodies in Brazilian brain tumor patients.
    Fonseca RF; Kawamura MT; Oliveira JA; Teixeira A; Alves G; Carvalho Mda G
    Genet Mol Res; 2003 Jun; 2(2):185-90. PubMed ID: 14966683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The glio-fibrillar acid protein in blood serum of patients with brain tumors and neurological diseases of non-tumorous etiology].
    Lyubimova NV; Timofeiev YS; Sushlinskii NE
    Klin Lab Diagn; 2016 Aug; 61(8):466-9. PubMed ID: 30601636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Difference in CDDP penetration into CSF between selective intraarterial chemotherapy in patients with malignant glioma and intravenous or intracarotid administration in patients with metastatic brain tumor.
    Nakagawa H; Fujita T; Kubo S; Tokiyoshi K; Yamada M; Kanayama T; Hagiwara Y; Nakanomyo H; Hiraoka M
    Cancer Chemother Pharmacol; 1996; 37(4):317-26. PubMed ID: 8548876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum levels of glial fibrillary acidic protein correlate to tumour volume of high-grade gliomas.
    Brommeland T; Rosengren L; Fridlund S; Hennig R; Isaksen V
    Acta Neurol Scand; 2007 Dec; 116(6):380-4. PubMed ID: 17986096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Specific cerebral alpha 1-globulin in glial tumors].
    Obukhov SK
    Zh Vopr Neirokhir Im N N Burdenko; 1985; (4):43-7. PubMed ID: 2413665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum concentrations of soluble interleukin-2 receptor in patients with malignant brain tumors.
    Yoshida S; Morii K
    J Surg Oncol; 2000 Oct; 75(2):131-5. PubMed ID: 11064393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The occurrence of tumors of the central nervous system in a clinical observation.
    Pastuszak Ż; Tomczykiewicz K; Piusińska-Macoch R; Stępień A; Kordowska J
    Pol Merkur Lekarski; 2015 Feb; 38(224):88-92. PubMed ID: 25771517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
    Bartus RT; Snodgrass P; Dean RL; Kordower JH; Emerich DF
    Exp Neurol; 2000 Jan; 161(1):234-44. PubMed ID: 10683290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients.
    Shi R; Wang PY; Li XY; Chen JX; Li Y; Zhang XZ; Zhang CG; Jiang T; Li WB; Ding W; Cheng SJ
    Oncotarget; 2015 Sep; 6(29):26971-81. PubMed ID: 26284486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical trial of MCNU for malignant brain tumors].
    Harada K; Okamoto H; Fujioka Y; Uozumi T; Kiya K; Kitaoka T; Goishi A; Sasaki U; Shima T; Inagawa T
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1423-31. PubMed ID: 2990350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concentrations of carbamazepine and carbamazepine-10, 11-epoxide in serum, brain tumors and paratumorous cortex: a prospective study of 37 neurosurgically treated epileptic patients.
    Schnabel R; Rambeck B; May TW; Jürgens U; Lahl R
    Eur Neurol; 1994; 34(4):213-20. PubMed ID: 8082680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative apparent diffusion coefficients and T2 relaxation times in characterizing contrast enhancing brain tumors and regions of peritumoral edema.
    Oh J; Cha S; Aiken AH; Han ET; Crane JC; Stainsby JA; Wright GA; Dillon WP; Nelson SJ
    J Magn Reson Imaging; 2005 Jun; 21(6):701-8. PubMed ID: 15906339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum levels of S-100B protein and neuron-specific enolase in glioma patients: a pilot study.
    Vos MJ; Postma TJ; Martens F; Uitdehaag BM; Blankenstein MA; Vandertop WP; Slotman BJ; Heimans JJ
    Anticancer Res; 2004; 24(4):2511-4. PubMed ID: 15330206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutoff value of choline concentration reliably reveals high-grade brain tumors among other contrast-enhancing brain lesions.
    Porto L; Hattingen E; Stuecher A; Herminghaus S; Lanfermann H; Ulrich Pilatus UP
    J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):147-52. PubMed ID: 22190143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized study of paclitaxel and tamoxifen deposition into human brain tumors: implications for the treatment of metastatic brain tumors.
    Fine RL; Chen J; Balmaceda C; Bruce JN; Huang M; Desai M; Sisti MB; McKhann GM; Goodman RR; Bertino JS; Nafziger AN; Fetell MR
    Clin Cancer Res; 2006 Oct; 12(19):5770-6. PubMed ID: 17020983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated levels of head activator in human brain tumors and in serum of patients with brain and other neurally derived tumors.
    Schaller HC; Schilling E; Theilmann L; Bodenmüller H; Sachsenheimer W
    J Neurooncol; 1988 Nov; 6(3):251-8. PubMed ID: 3225643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.